Purchase Order 75F40124P00431
Award Date 8/31/24
Potential Completion Date 9/29/29
Potential Value $425K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Laurel, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for $170,153.16 to provide annual on-site preventative maintenance service and unlimited repairs as needed on two Illumina MiSeq whole genome sequencers for a base year plus four option years. The contract has no set-aside designation. Based on Illumina's history as a prime contractor and subcontractor for sequencing systems and services across various federal agencies, this award aligns...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the service and maintenance of one Illumina MiSeq sequencing system, with a ceiling value of $34,972.40 and a performance period ending on September 24, 2024. Illumina, a for-profit organization and manufacturer of goods, has been awarded numerous prime federal contracts and...
- This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $21,183, is for the provision of preventative maintenance services for Illumina's MiSeq benchtop sequencer. The contract does not have a set-aside designation. Illumina has extensive experience providing sequencing systems, reagents, and maintenance services to a variety of...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the repair and maintenance of seven Illumina MiSeq instruments owned by the FDA's Center for Food Safety and Applied Nutrition (CFSAN). The contract includes a base period of performance through December 30, 2027, with four one-year option periods. The total ceiling value of the contract is $422,733.60. Illumina, a manufacturer of sequencing and genomic analysis instruments and...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $89,573.00, is for preventative maintenance and repair services for the agency's MiSeq sequencing system. The contract has an ultimate completion date of April 30, 2028 and does not include any set-aside designation. Illumina has previously provided a range of sequencing instruments, reagents, and...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic analysis technologies. The contract, with a ceiling value of $417,372.48, is for preventative maintenance services on Illumina's NextSeq 2000 and NextSeq 500 sequencing platforms. The award does not utilize a set-aside designation. Illumina is a leading provider of genetic sequencing instruments, reagents, and...
- This is a firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for an annual maintenance agreement covering seven Illumina sequencing instruments. The contract has a base year and four option years, with a total potential value of $817,521.04. Illumina, a manufacturer of sequencing and genomic analysis technologies, has a history of providing sequencing systems, reagents, and maintenance services to federal agencies for various research and...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $66,483.01, is for a Preventive Maintenance and Repair Agreement for an Illumina MiSeq system. The contract has an ultimate completion date of May 16, 2025 and does not utilize any set-aside designations. Illumina has been awarded numerous prime federal contracts and grants...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and related products, for the provision of a MiSeq sequencing instrument and a one-year preventative maintenance agreement. The total potential value of this contract is $109,857.00. Illumina has a history of providing sequencing systems and services to support genomic research and diagnostics across various federal...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for $12,450.00 to provide preventative maintenance services for Illumina's MISEQ sequencing system. The contract has an ultimate completion date of June 30, 2018 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...